This shifted metabolic framework points to the relevance of recognizing elevated insulin as a key PCOS feature even in the absence of aberrant glucose homeostasis, and highlights the importance of developing new and proactive management strategies to specifically prevent or suppress hyperinsulinemia rather than targeting insulin resistance or glucose levels (Nolan & Prentki 2019). The gene discussed is INS; the disease is Insulin resistance.